Chauncey Leake Distinguished Professor, Vice Chairman, Pharmacology and Toxicology, Director, Center for Addiction Research, UT Medical Branch at Galveston
Dr. Cunningham and her team have made multiple contributions to our understanding of the neuropsychopharmacology of abused drugs and psychotherapeutics, the underlying neurobiology of behavior, and new target and drug discovery in neuropsychiatric conditions. With established strengths in pharmacology and neuroscience, Dr. Cunningham focuses on advancing the biological understanding of disorders with an addictive dimensionality (e.g., drug addiction, binge eating disorder, obesity) and developing effective and safe therapeutics to maximize human function. A primary focus is our cross-disciplinary, translational research efforts with medicinal and synthetic chemists, cell biologists, neuropharmacologists, and clinical scientists to pinpoint the critical roles of two serotonin proteins (5-HT2A and 5-HT2C receptors) in cocaine use disorder and the discovery of novel serotonergic medications to extend abstinence. Chemists and engineering collaborators Drs. Scott Gilbertson (University of Houston), Jai Rudra and Jia Zhou, work closely with Dr. Cunningham's laboratory on additional novel targets for therapeutics and neuroprobes. To facilitate this effort, we have established new cellular, behavioral and molecular screening tools to study these systems.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Research Consortia
John S. Dunn GCC for Chemical Genomics
Gulf Coast Cluster for Translational Addiction Science
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.